fbpx

DPC Files Amicus Brief in Supreme Court Case

2024-03-29T01:10:10+00:00January 27th, 2022|Categories: Article, Dialysis Funding, Legal Defense, Medicare Advantage, Private Insurance Coverage, Protect Patient Care|

DPC filed a “friend of the court” brief in the U.S. Supreme Court case of Marietta Memorial Hospital v. DaVita. The case involves a dialysis patient whose employer-sponsored health insurance plan tied reimbursements for dialysis to Medicare prices. The Sixth Circuit Court of Appeals held that this constituted illegal discrimination. The employer appealed the decision, which is now scheduled for oral arguments before the U.S. Supreme Court on March 1. DPC’s brief argues that such discrimination circumvents dialysis patients’ right to keep their employer coverage for up to 30 months before Medicare becomes their private insurance. DPC emphasized the three [...]

2021 Annual Survey Last Call!

2024-03-29T01:10:13+00:00August 26th, 2021|Categories: 5-Star Ratings, Access to Transplant, Article, Care Coordination, Charitable Premium Assistance, Dental Coverage, Dialysis Funding, Immunosuppressive Drug Coverage, Innovation, Medicaid, Medicare Advantage, Medigap Coverage, Patient's Voice, Protect Patient Care, Quality Incentive Program, Take Action, Transplant Donor Protection, Transportation Services, Treatment Options|Tags: |

24 hours remain to complete our survey. Make sure to complete your survey for a chance at one of 10 remaining $100 gift certificates. Our 2021 Annual Membership Survey is live, and it will remain open until Friday, August 27. Your feedback helps to shape our public policy agenda and patient education priorities for the next year. This year we ask that both patients and caregivers take our survey. Rest assured your responses will remain completely anonymous. We only share the overall survey results with state and federal level policy makers, so they will better understand your needs, experiences, and [...]

Both Sides of the Aisle Agree – We Need to Help Kidney Patients

2024-03-29T01:10:15+00:00June 9th, 2021|Categories: Advance Patient Choice, Dialysis Funding, Improve Access to Care, Increase Quality of Care, Innovation, Medicare Advantage, Medigap Coverage, Protect Patient Care|

On June 8, 2021, Senators Benjamin Cardin (D-MA) and Roy Blunt (R-MO) re-introduced The Chronic Kidney Disease Improvement in Research and Treatment Act (S.1971), a bipartisan, bicameral bill designed to not only raise awareness of chronic kidney disease (CKD) and end-stage renal disease (ESRD), but also improve understanding and access to treatment for patients, which includes the Jack Reynolds Memorial Medigap Expansion Act. The latest statistics from the Centers for Disease Control and Prevention estimates that more that 1 in 7 US adults (about 37 million people) have CKD and that as many as 9 out of 10 of those adults [...]

New Year, New Administration Brings Changes to Medicare’s Kidney Demonstration Projects

2024-03-29T01:10:16+00:00April 14th, 2021|Categories: Article, Care Coordination, Dialysis Funding, Medicare Advantage, Protect Patient Care, Quality Incentive Program|

2021 was supposed to mark the beginning of three new Medicare programs to demonstrate innovations in kidney care, but a last-minute decision from the Center for Medicare and Medicaid Innovation has suspended two of them. This action unfortunately leaves about 50,000 dialysis patients with a nine-month gap in extra assistance they were receiving from a successful program that expired March 31. Here is the rundown on the current landscape of Medicare demonstration projects that impact dialysis patients. Demonstration projects are used by Medicare to test new models of care and/or new models of paying providers within Medicare’s traditional fee-for-service program. [...]

In Rejecting Prop 23, California Voters Protect Patient Access to Care

2024-03-29T01:12:01+00:00November 10th, 2020|Categories: Article, Dialysis Funding, Improve Access to Care, State Advocacy|

California voters overwhelmingly opposed Proposition 23, a statewide measure that threatened dialysis patient access to care. It was the second ballot measure in California proposed by a labor union in the last two years and the second resounding defeat for the union, and this time by an even wider margin than in 2018. DPC was part of a broad and diverse coalition that included other patient advocacy organizations, dialysis providers and caregivers, and groups representing physicians, nurses, veterans and social justice communities that opposed this harmful measure because it threatened patients’ access to care and would have increased overall health care costs [...]

CMS Announces Penalties and Rewards for Promoting Home Dialysis and Transplants

2024-03-29T01:12:02+00:00September 22nd, 2020|Categories: Access to Transplant, Article, Dialysis Funding, Transplant Donor Protection, Treatment Options|

On September 18, the Centers for Medicare & Medicaid Services (CMS) announced it finalized the End-Stage Renal Disease Treatment Choices (ETC) Model. The ETC Model was a cornerstone of President Trump’s Advancing Kidney Health Executive Order in 2019. It encourages an increased use of home dialysis and kidney transplants in approximately 30 percent of dialysis facilities and nephrology practices and will be implemented on January 1, 2021. CMS estimated reduced expenditures of $23 million over five and a half years, anticipating that providers assigned to the program will be penalized for not meeting standards. DPC and many other kidney groups opposed this [...]

DPC’s 2020 Annual Membership Survey is Live!

2024-03-29T01:12:03+00:00August 6th, 2020|Categories: 5-Star Ratings, Access to Transplant, Article, Care Coordination, Charitable Premium Assistance, Dental Coverage, Dialysis Funding, Get Involved, Immunosuppressive Drug Coverage, Innovation, Medicaid, Medicare Advantage, Medigap Coverage, Quality Incentive Program, Take Action, Transplant Donor Protection, Transportation Services, Treatment Options|Tags: |

Elevate the Voice of Patients with Kidney Disease and Their Caregivers Our 2020 Annual Membership Survey is live, and it will remain open until Friday, August 21. We are counting on your participation, as patient feedback helps to shape our public policy agenda and patient education priorities for the next year. This year we ask that both patients and caregivers take our survey. Rest assured your responses will remain completely anonymous. We only share the overall survey results with state and federal level policy makers, so they will better understand your needs, experiences, and preferences. Your feedback is crucial. Therefore, we will [...]

Happy Holidays and DPC’s Top 10 Accomplishments of 2019

2024-03-29T01:13:32+00:00December 20th, 2019|Categories: 5-Star Ratings, About DPC, Access to Transplant, Article, Care Coordination, Charitable Premium Assistance, Dental Coverage, Dialysis Funding, Immunosuppressive Drug Coverage, Innovation, Medicaid, Medicare Advantage, Medigap Coverage, Quality Incentive Program, Transplant Donor Protection, Transportation Services, Treatment Options|

Dialysis Patient Citizens wants to wish you and your family a Happy Holiday, as well as a safe and healthy New Year. Our offices will be closed for the holidays starting December 23 through January 1. We also want to take this opportunity to share our list of Top 10 Accomplishments for 2019, which would not have been possible without your support. Thank you again for helping us elevate the dialysis patient voice with policy makers. We are extremely grateful for all of your advocacy efforts, and we look forward to our continued collaboration in 2020 as we work together to improve dialysis [...]

DPC Advocates for Patient Access to Private Health Insurance

2024-03-29T01:13:33+00:00October 30th, 2019|Categories: Article, Dialysis Funding, Improve Access to Care, Legal Defense, Private Insurance Coverage, Promote Financial Security|Tags: |

DPC filed an amicus brief in support of a lawsuit to protect patient access to private health insurance coverage. This is one of a number of lawsuits challenging discrimination by employer health plans in how they pay for dialysis. End-Stage Renal Disease (ESRD) patients are protected by the Medicare Secondary Payer Act (MSP), which permits ESRD patients to remain on their private health insurance plans for 30 months before they must enroll in Medicare. To protect this right from being chipped away, Congress prohibited health plans from making any distinctions in how they cover dialysis relative to how other treatments or diseases are [...]

DPC Comments on CMS Proposed ESRD Annual Payment Rule to Improve Dialysis Patient Quality of Life

2024-03-29T01:13:33+00:00October 11th, 2019|Categories: Access to Transplant, Article, Charitable Premium Assistance, Comment Letter, Dental Coverage, Dialysis Funding, Innovation, Medicare Advantage, Quality Incentive Program, Treatment Options|

Each year—typically during the summer—the Centers for Medicare and Medicaid Services (CMS) puts out rules for how they are going to pay for dialysis treatment. The rules reflect CMS' latest policies, and organizations have the opportunity to provide feedback about the rules before they go into effect on January 1. DPC provided feedback to CMS regarding their end-stage renal disease (ESRD) Annual Payment rule. DPC's letter addresses the following important topics for improving ESRD patient care: Transitional Add-On Payment Adjustment for New and Innovative Equipment and Supplies Anemia Management Social Risk Factors and their Impact on the QIP The Need [...]

Go to Top